Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.10.0.1
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2018
Equity [Abstract]  
Preferred Stock The following table presents cash dividends declared by the Company on its preferred stock since their issuances:
Declaration Date
 
Record Date
 
Payment Date
 
Cash Dividend Per Preferred Share
Series A Preferred Stock:
 
 
 
 
 
 
September 20, 2018
 
October 12, 2018
 
October 29, 2018
 
$
0.507810

June 19, 2018
 
July 12, 2018
 
July 27, 2018
 
$
0.507810

March 20, 2018
 
April 12, 2018
 
April 27, 2018
 
$
0.507810

December 14, 2017
 
January 12, 2018
 
January 29, 2018
 
$
0.507810

September 14, 2017
 
October 12, 2017
 
October 27, 2017
 
$
0.507810

June 15, 2017
 
July 12, 2017
 
July 27, 2017
 
$
0.750430

Series B Preferred Stock:
 
 
 
 
 
 
September 20, 2018
 
October 12, 2018
 
October 29, 2018
 
$
0.476560

June 19, 2018
 
July 12, 2018
 
July 27, 2018
 
$
0.476560

March 20, 2018
 
April 12, 2018
 
April 27, 2018
 
$
0.476560

December 14, 2017
 
January 12, 2018
 
January 29, 2018
 
$
0.476560

September 14, 2017
 
October 12, 2017
 
October 27, 2017
 
$
0.518920

Series C Preferred Stock:
 
 
 
 
 
 
September 20, 2018
 
October 12, 2018
 
October 29, 2018
 
$
0.453130

June 19, 2018
 
July 12, 2018
 
July 27, 2018
 
$
0.453130

March 20, 2018
 
April 12, 2018
 
April 27, 2018
 
$
0.453130

December 14, 2017
 
January 12, 2018
 
January 29, 2018
 
$
0.302080

Series D Preferred Stock:
 
 
 
 
 
 
September 20, 2018
 
October 1, 2018
 
October 15, 2018
 
$
0.484375

Series E Preferred Stock:
 
 
 
 
 
 
September 20, 2018
 
October 1, 2018
 
October 15, 2018
 
$
0.468750

Schedule of Stock by Class The following table presents a reconciliation of the common shares outstanding for the nine months ended September 30, 2018 and 2017:
 
Number of common shares
Common shares outstanding, December 31, 2016
173,826,163

Issuance of common stock
19,688

Issuance of restricted stock (1)
643,505

Common shares outstanding, September 30, 2017
174,489,356

 
 
Common shares outstanding, December 31, 2017
174,496,587

Issuance of common stock
72,608,932

Issuance of restricted stock (1)
972,651

Common shares outstanding, September 30, 2018
248,078,170

____________________
(1)
Represents shares of restricted stock granted under the Second Restated 2009 Equity Incentive Plan, net of forfeitures, of which 1,593,701 restricted shares remained subject to vesting requirements at September 30, 2018.
Dividends Declared The following table presents cash dividends declared by the Company on its common stock from December 31, 2016 through September 30, 2018:
Declaration Date
 
Record Date
 
Payment Date
 
Cash Dividend Per Common Share
September 20, 2018
 
October 1, 2018
 
October 29, 2018
 
$
0.311630

July 13, 2018
 
July 25, 2018
 
July 30, 2018
 
$
0.158370

June 19, 2018
 
June 29, 2018
 
July 27, 2018
 
$
0.470000

March 20, 2018
 
April 2, 2018
 
April 27, 2018
 
$
0.470000

December 14, 2017
 
December 26, 2017
 
December 29, 2017
 
$
0.470000

September 14, 2017
 
September 29, 2017
 
October 27, 2017
 
$
0.520000

June 15, 2017
 
June 30, 2017
 
July 27, 2017
 
$
0.520000

March 14, 2017
 
March 31, 2017
 
April 27, 2017
 
$
0.500000

Schedule of Accumulated Other Comprehensive Income (Loss) Accumulated other comprehensive (loss) income at September 30, 2018 and December 31, 2017 was as follows:
(in thousands)
September 30,
2018
 
December 31,
2017
Available-for-sale securities
 
 
 
Unrealized gains
$
522,365

 
$
475,694

Unrealized losses
(677,094
)
 
(140,881
)
Accumulated other comprehensive (loss) income
$
(154,729
)
 
$
334,813

Reclassification out of Accumulated Other Comprehensive Income The following table summarizes reclassifications out of accumulated other comprehensive income for the three and nine months ended September 30, 2018 and 2017:
 
 
Affected Line Item in the Condensed Consolidated Statements of Comprehensive (Loss) Income
 
Amount Reclassified out of Accumulated Other Comprehensive (Loss) Income
 
 
 
 
Three Months Ended
 
Nine Months Ended
(in thousands)
 
 
 
September 30,
 
September 30,
 
 
 
 
2018
 
2017
 
2018
 
2017
Other-than-temporary impairments on AFS securities
 
Total other-than-temporary impairment losses
 
$
95

 
$

 
$
363

 
$
429

Realized losses (gains) on sales of certain AFS securities, net of tax
 
(Loss) gain on investment securities
 
30,368

 
4,220

 
52,654

 
7,386

Total
 
 
 
$
30,463

 
$
4,220

 
$
53,017

 
$
7,815